Display options
Cite
Na HN, Kim H, Nam JH. Prophylactic and therapeutic vaccines for obesity. Clin Exp Vaccine Res. 2013;3(1):37-41doi: 10.7774/cevr.2014.3.1.37.
Na, H. N., Kim, H., & Nam, J. H. (2014). Prophylactic and therapeutic vaccines for obesity. Clinical and experimental vaccine research, 3(1), 37-41. https://doi.org/10.7774/cevr.2014.3.1.37
Na, Ha-Na, et al. "Prophylactic and therapeutic vaccines for obesity." Clinical and experimental vaccine research vol. 3,1 (2014): 37-41. doi: https://doi.org/10.7774/cevr.2014.3.1.37
Na HN, Kim H, Nam JH. Prophylactic and therapeutic vaccines for obesity. Clin Exp Vaccine Res. 2014 Jan;3(1):37-41. doi: 10.7774/cevr.2014.3.1.37. Epub 2013 Dec 18. PMID: 24427761; PMCID: PMC3890448.
Copy Download .nbib Format: NLM
Share it on

Clin Exp Vaccine Res. 2014 Jan;3(1):37-41. doi: 10.7774/cevr.2014.3.1.37. Epub 2013 Dec 18.

Prophylactic and therapeutic vaccines for obesity.

Clinical and experimental vaccine research

Ha-Na Na, Hun Kim, Jae-Hwan Nam

Affiliations

  1. Department of Infection and Obesity, Pennington Biomedical Research Center, Baton Rouge, LA, USA.
  2. SK Chemicals, Seongnam, Korea.
  3. Department of Biotechnology, The Catholic University of Korea, Bucheon, Korea.

PMID: 24427761 PMCID: PMC3890448 DOI: 10.7774/cevr.2014.3.1.37

Abstract

Chronic diseases such as obesity and diabetes are major causes of death and disability throughout the world. Many causes are known to trigger these chronic diseases, and infectious agents such as viruses are also pathological factors. In particular, it is considered that adenovirus 36 infections may be associated with obesity. If this is the case, a vaccine against adenovirus 36 may be a form of prophylaxis to combat obesity. Other types of therapeutic vaccines to combat obesity are also being developed. Recently, hormones such as glucagon-like peptide-1, ghrelin, and peptide YY have been studied as treatments to prevent obesity. This review describes the ongoing development of therapeutic vaccines to treat obesity, and the possibility of using inactivated adenovirus 36 as a vaccine and an anti-obesity agent.

Keywords: Adenovirus 36; Obesity; Vaccine

References

  1. J Immunol. 2009 Sep 15;183(6):3788-99 - PubMed
  2. Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13226-31 - PubMed
  3. FASEB J. 2004 Mar;18(3):439-56 - PubMed
  4. Immunity. 2011 Mar 25;34(3):375-84 - PubMed
  5. Science. 2004 Mar 5;303(5663):1526-9 - PubMed
  6. Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2815-22 - PubMed
  7. J Clin Endocrinol Metab. 2004 Dec;89(12):5993-7 - PubMed
  8. Curr Opin Immunol. 2010 Jun;22(3):391-6 - PubMed
  9. Nat Rev Endocrinol. 2011 Nov 08;8(4):228-36 - PubMed
  10. Pediatrics. 2010 Oct;126(4):721-6 - PubMed
  11. Am J Physiol Endocrinol Metab. 2012 Dec 15;303(12):E1479-88 - PubMed
  12. J Clin Endocrinol Metab. 2001 Oct;86(10):4753-8 - PubMed
  13. Nat Rev Drug Discov. 2006 May;5(5):369-70 - PubMed
  14. Lancet. 2007 Jan 6;369(9555):71-7 - PubMed
  15. JAMA. 1985 Dec 13;254(22):3187-9 - PubMed
  16. J Nutr. 2002 Oct;132(10):3155-60 - PubMed
  17. Int J Obes (Lond). 2005 Mar;29(3):281-6 - PubMed
  18. Diabetes Metab Syndr Obes. 2010 Jul 16;3:253-62 - PubMed
  19. J Infect Dis. 2012 Jan 15;205(2):244-51 - PubMed
  20. Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):314-21 - PubMed
  21. N Engl J Med. 2007 Aug 23;357(8):753-61 - PubMed
  22. Obes Rev. 2001 May;2(2):131-40 - PubMed
  23. Int J Obes (Lond). 2009 Dec;33(12):1402-9 - PubMed
  24. Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2017-21 - PubMed
  25. Diabet Med. 2002 Aug;19(8):619-27 - PubMed
  26. N Engl J Med. 2007 Aug 23;357(8):741-52 - PubMed
  27. J Med Virol. 2001 Jul;64(3):290-8 - PubMed
  28. Med Hypotheses. 2009 Apr;72(4):383-8 - PubMed
  29. Gene. 1993 Dec 27;137(1):133-7 - PubMed
  30. Int J Obes (Lond). 2010 Jan;34(1):89-93 - PubMed
  31. Arch Virol. 2008;153(11):2097-102 - PubMed
  32. Science. 1986 Jun 20;232(4757):1545-7 - PubMed
  33. Int J Obes Relat Metab Disord. 2001 Jul;25(7):990-6 - PubMed
  34. JAMA. 2005 Jan 5;293(1):43-53 - PubMed
  35. Curr Opin Struct Biol. 2000 Apr;10(2):229-35 - PubMed
  36. Nature. 2006 Dec 14;444(7121):840-6 - PubMed
  37. Int J Obes Relat Metab Disord. 2000 Aug;24(8):989-96 - PubMed
  38. Obes Rev. 2007 Jan;8(1):21-34 - PubMed
  39. Eur J Immunol. 2008 Mar;38(3):877-87 - PubMed
  40. Int J Pediatr Obes. 2010 Apr;5(2):157-60 - PubMed
  41. FEBS Lett. 1999 Jan 8;442(1):1-6 - PubMed
  42. J Clin Endocrinol Metab. 2011 Jun;96(6):1654-63 - PubMed

Publication Types